MEDIPOINT

K982961 · Medipoint , Ltd. · GZJ · Jun 7, 1999 · Neurology

Device Facts

• Record ID: K982961
• Device Name: MEDIPOINT
• Applicant: Medipoint , Ltd.
• Product Code: GZJ · Neurology
• Decision Date: Jun 7, 1999
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 882.5890
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

MEDIPOINT is intended for relief of chronic or acute pain.

Device Story

MEDIPOINT is a portable, hand-held, battery-operated microcurrent pulse generator. It delivers a minute biphasic DC current to provide transcutaneous electrical nerve stimulation (TENS) for pain relief. The device is intended for the management of chronic or acute pain. It is operated by the user or a clinician to deliver electrical pulses to the site of pain.

Technological Characteristics

Portable, hand-held, battery-operated microcurrent pulse generator. Delivers biphasic DC current. Classified as a transcutaneous electrical nerve stimulator (21 CFR 882.5890).

Indications for Use

Indicated for the relief of chronic and post-traumatic acute pain (TENS).

Regulatory Classification

Identification

A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.

Predicate Devices

• SOLITENS™ (K913522)

Submission Summary (Full Text)

{0}------------------------------------------------

Medipoint Ltd. 12 Wolfe Close Parkgate Business Park, Knutsford Cheshire, WA16 8XJ, UK

K982961

MEDIPOINT 510(K) Premarket Notification Dated: August 5, 1998

# 510(k) Summary 10.

# MEDIPOINT, MICROCURRENT THERAPY

Contact: Larry Ratliff Medipoint USA Pocatella, Idaho 83204

Tel: [phone]

Sponsor: Medipoint Ltd. 12 Wolfe Close Parkgate Business Park, Knutsford Chesire, WA16 8XJ, UK

Tel: [phone]

Notice: This document is propriety and its contents are the exclusive property of Medipoint Ltd. This ડી document may not be reproduced in any form without the specific permission of Medipoint Ltd.

ﺔ ﺍﻟﻤ

イ

۰۰

で

0

{1}------------------------------------------------

MEDIPOINT 510(K) Premarket Notification Dated: August 5, 1998

K982961

## 10. 1. Device Name

MEDIPOINT is provided as follows:

- a. Trade Name MEDIPOINT
- b. Common Name Microcurrent Therapy
- c. Classification Name
- 21 CFR Sec. 882.5890 Transcutaneous electrical nerve stimulator . for pain relief

## 10. 2. Predicate Device / Company Names and Addresses

The predicate device is listed below with its 510(k) clearance number.

| SOLITENS™ | K(913522) | INNOVATIVE DESIGNER PRODUCTS, INC.<br>Saul Liss<br>175 Rock Road<br>Glen Rock, NJ 07452 |
|-----------|-----------|-----------------------------------------------------------------------------------------|
|-----------|-----------|-----------------------------------------------------------------------------------------|

#### 10. 3. Description of Device

MEDIPOINT is a portable hand held battery operated micro current pulse generator Pusing a very minute biphasic DC current.

#### 10. 4. Intended Use

MEDIPOINT is intended for relief of chronic or acute pain.

Notice: This document is propriety and its contents are the exclusive property of Medipoint Ltd. This ട് 2 document may not be reproduced in any form without the specific permission of Medipoint Ltd.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized human figure with three lines extending from its head, resembling a bird in flight. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the figure.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN 7 1999

Jules T. Mitchel, Ph.D. Target Health Inc. Representing Medipoint_Limited Representing nearpoint 22mlood New York, New York 10017

K982961 Re: Medipoint Trade Name: Requlatory Class: II Product Code: GZJ March 9, 1999 Dated: March 10, 1999 Received:

Dear Dr. Mitchel:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{3}------------------------------------------------

Page 2 - Jules T. Mitchel, Ph.D.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note one regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, PH.D., M.D.
Director
Division of General and

Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Attachment I b

Page / of /

| <strong>Labels</strong> | <strong>Values</strong> |
|---------------------------|-------------------------|
| 510(k) Number (if known): | K982961 |
| Device Name: | Mediprint |

Indications For Use:

MEDIPOINT is an electronic pulse generator that has been designed to provide in MEDIPOINT IS an electionic pulse generator that has has has and post-traumatic acute pain (TENS).

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Division Sign-Off
Division of General Restorative Devices

(Division Sign-Off)
Division of General Restorative Devices
510(k) Number K98296

Prescription Use (Per 21 CFR 801.109)

OR

Over-The-Counter Use

(Optional Format 1-2-96)